Clinical Trial Update: High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin's Lymphoma or Central Nervous System (CNS) Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating high-dose chemotherapy with stem cell transplant for Non-Hodgkin's Lymphoma and CNS Lymphoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cns Lymphoma
• Non-hodgkin Lymphoma

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Non-Hodgkin's Lymphoma, CNS Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2017-12-29